129 related articles for article (PubMed ID: 32613842)
21. The correlation between low vitamin D status and renal interleukin-6/STAT3 hyper-activation in patients with clear cell renal cell carcinoma.
Song J; Xu S; Zhang ZH; Chen YH; Gao L; Xie DD; Sun GP; Yu DX; Xu DX
Steroids; 2019 Oct; 150():108445. PubMed ID: 31295461
[TBL] [Abstract][Full Text] [Related]
22. Fine needle aspiration biopsy of epithelioid angiomyolipoma. A case report.
Mai KT; Yazdi HM; Perkins DG; Thijssen A
Acta Cytol; 2001; 45(2):233-6. PubMed ID: 11284309
[TBL] [Abstract][Full Text] [Related]
23. Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin.
Schaeffeler E; Büttner F; Reustle A; Klumpp V; Winter S; Rausch S; Fisel P; Hennenlotter J; Kruck S; Stenzl A; Wahrheit J; Sonntag D; Scharpf M; Fend F; Agaimy A; Hartmann A; Bedke J; Schwab M
Eur Urol Focus; 2019 Jul; 5(4):608-618. PubMed ID: 29452772
[TBL] [Abstract][Full Text] [Related]
24. Serum microRNA Expression Profiling: Potential Diagnostic Implications of a Panel of Serum microRNAs for Clear Cell Renal Cell Cancer.
Yadav S; Khandelwal M; Seth A; Saini AK; Dogra PN; Sharma A
Urology; 2017 Jun; 104():64-69. PubMed ID: 28336290
[TBL] [Abstract][Full Text] [Related]
25. Combination of serum histidine and plasma tryptophan as a potential biomarker to detect clear cell renal cell carcinoma.
Lee HO; Uzzo RG; Kister D; Kruger WD
J Transl Med; 2017 Apr; 15(1):72. PubMed ID: 28385150
[TBL] [Abstract][Full Text] [Related]
26.
Lin W; Chen X; Chen T; Liu J; Ye Y; Chen L; Qiu X; Chia-Hsien Cheng J; Zhang L; Wu J; Qiu S
DNA Cell Biol; 2020 Jun; 39(6):1000-1011. PubMed ID: 32282241
[TBL] [Abstract][Full Text] [Related]
27. Differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma in contrast-enhanced MDCT images using quantitative feature classification.
Lee HS; Hong H; Jung DC; Park S; Kim J
Med Phys; 2017 Jul; 44(7):3604-3614. PubMed ID: 28376281
[TBL] [Abstract][Full Text] [Related]
28. Predictive Value of Chemical-Shift MRI in Distinguishing Clear Cell Renal Cell Carcinoma From Non-Clear Cell Renal Cell Carcinoma and Minimal-Fat Angiomyolipoma.
Jhaveri KS; Elmi A; Hosseini-Nik H; Hedgire S; Evans A; Jewett M; Harisinghani M
AJR Am J Roentgenol; 2015 Jul; 205(1):W79-86. PubMed ID: 26102422
[TBL] [Abstract][Full Text] [Related]
29. A CT-based radiomics nomogram for differentiation of renal angiomyolipoma without visible fat from homogeneous clear cell renal cell carcinoma.
Nie P; Yang G; Wang Z; Yan L; Miao W; Hao D; Wu J; Zhao Y; Gong A; Cui J; Jia Y; Niu H
Eur Radiol; 2020 Feb; 30(2):1274-1284. PubMed ID: 31506816
[TBL] [Abstract][Full Text] [Related]
30. Dialysis modality-dependent changes in serum metabolites: accumulation of inosine and hypoxanthine in patients on haemodialysis.
Choi JY; Yoon YJ; Choi HJ; Park SH; Kim CD; Kim IS; Kwon TH; Do JY; Kim SH; Ryu DH; Hwang GS; Kim YL
Nephrol Dial Transplant; 2011 Apr; 26(4):1304-13. PubMed ID: 20844182
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic test accuracy of ADC values for identification of clear cell renal cell carcinoma: systematic review and meta-analysis.
Tordjman M; Mali R; Madelin G; Prabhu V; Kang SK
Eur Radiol; 2020 Jul; 30(7):4023-4038. PubMed ID: 32144458
[TBL] [Abstract][Full Text] [Related]
32. Angiomyolipoma with minimal fat: differentiation from clear cell renal cell carcinoma and papillary renal cell carcinoma by texture analysis on CT images.
Yan L; Liu Z; Wang G; Huang Y; Liu Y; Yu Y; Liang C
Acad Radiol; 2015 Sep; 22(9):1115-21. PubMed ID: 26031228
[TBL] [Abstract][Full Text] [Related]
33. [CT differentiation of renal angiomyolipoma and renal cell carcinoma].
Zhu J; Liu RB; Zhou XP; Wu ZF; Lu CY; Wang N
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 36(2):257-60. PubMed ID: 15807282
[TBL] [Abstract][Full Text] [Related]
34. Quantification of carbonic anhydrase IX expression in serum and tissue of renal cell carcinoma patients using enzyme-linked immunosorbent assay: prognostic and diagnostic potentials.
Zhou GX; Ireland J; Rayman P; Finke J; Zhou M
Urology; 2010 Feb; 75(2):257-61. PubMed ID: 19963243
[TBL] [Abstract][Full Text] [Related]
35. Identification of the molecular mechanism and diagnostic biomarkers in the thoracic ossification of the ligamentum flavum using metabolomics and transcriptomics.
Li J; Yu L; Guo S; Zhao Y
BMC Mol Cell Biol; 2020 May; 21(1):37. PubMed ID: 32404047
[TBL] [Abstract][Full Text] [Related]
36. Cystic angiomyolipoma mimicking cystic renal cell carcinoma.
Chung YE; Oh YT; Choi YD
J Urol; 2011 Mar; 185(3):1098-9. PubMed ID: 21256521
[No Abstract] [Full Text] [Related]
37. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.
Kroeze SG; Bijenhof AM; Bosch JL; Jans JJ
Cancer Biomark; 2010; 7(6):261-8. PubMed ID: 21694464
[TBL] [Abstract][Full Text] [Related]
38. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
[TBL] [Abstract][Full Text] [Related]
39. Serum level of immunosuppressive acidic protein in haemodialysis patients with or without renal cell carcinoma.
Sasagawa I; Nakada T; Kubota Y; Suzuki H; Sawamura T
Br J Urol; 1994 Apr; 73(4):355-7. PubMed ID: 8199820
[TBL] [Abstract][Full Text] [Related]
40. Application of ex vivo (1)H NMR metabonomics to the characterization and possible detection of renal cell carcinoma metastases.
Gao H; Dong B; Jia J; Zhu H; Diao C; Yan Z; Huang Y; Li X
J Cancer Res Clin Oncol; 2012 May; 138(5):753-61. PubMed ID: 22258851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
